Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and safety of LC2701 in healthy adult male subjects
jRCTs041250105Phase 1Active, not recruiting
- Sponsor
- Lead Chemical
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ramelteon, sponsored by Lead Chemical. Primary endpoints: Maximum plasma concentration (Cmax) of ramelteon and M-II, Time to reach maximum plasma concentration (Tmax) of ramelteon and M-II and 7 more. Started Nov 2025; status: active, not recruiting.
02
Drugs
ramelteon
Beyond the preview
Go deeper on jRCTs041250105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041250105.